Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

27.460
+1.0203.86%
Volume:20.99M
Turnover:575.09M
Market Cap:73.02B
PE:24.19
High:28.060
Open:26.440
Low:26.120
Close:26.440
52wk High:28.060
52wk Low:11.299
Shares:2.66B
HK Float Shares:541.00M
Volume Ratio:1.48
T/O Rate:3.88%
Dividend:0.35
Dividend Rate:1.27%
EPS(LYR):1.135
ROE:6.82%
ROA:1.37%
PB:1.41
PE(LYR):24.19
PS:1.66

Loading ...

Morgan Stanley Initiates Buy Rating on FOSUN PHARMA (02196) with A-Share Target Price of 42 RMB and H-Share Target Price of 33 HKD

Stock News
·
10 hours ago

Fosun Pharmaceutical Unit Gets China Nod for Lung Cancer Drug Trial

MT Newswires Live
·
Yesterday

Fosun Pharma's (600196.SH) Subsidiary Henlius Receives US FDA Approval for HLX17 Clinical Trial

Stock News
·
Yesterday

AH Stock Statistics | September 8

Stock News
·
Yesterday

AH Statistics | September 5

Stock News
·
Sep 05

Fosun Pharmaceutical Gets US FDA's Nod for Osteoporosis Drug

MT Newswires Live
·
Sep 02

AH Stock Statistics | September 1

Stock News
·
Sep 01

Over 2.8 Billion RMB! Fosun Pharma Subsidiary Delivers Outstanding First-Half Performance

Deep News
·
Aug 29

FOSUN PHARMA (02196): Fosun Pharma Industry Signs License Agreement with Akeso

Stock News
·
Aug 29

Hong Kong Stock Alert | FOSUN PHARMA (02196) Surges Nearly 5% in Early Trading as Interim Net Profit Jumps Nearly 40% YoY, Grants Overseas Development Rights to Sitala

Stock News
·
Aug 28

FOSUN PHARMA (02196): Drug Registration Application for Vincristine Sulfate Injection Accepted by National Medical Products Administration

Stock News
·
Aug 26

Press Release: Fosun Pharma Announces 2025 Interim Results

Dow Jones
·
Aug 26

FOSUN PHARMA (02196) Reports 2025 Interim Results with Improved Operating Cash Flow and Continued Innovation Transformation

Stock News
·
Aug 26

FOSUN PHARMA Plans Stock Incentive Program to Reinforce Innovation Transformation and Growth Confidence

Deep News
·
Aug 25

FOSUN PHARMA (02196) Plans to Launch 2025 A-Share Stock Option Incentive Program

Stock News
·
Aug 22

Hong Kong Stock Movement | FOSUN PHARMA (02196) Surges Over 6% Again as Small Molecule Oral DPP-1 Inhibitor Licensed Overseas, Supporting Revaluation of Innovative Drug Pipeline

Stock News
·
Aug 15

Innovation Gains International Recognition as AH-Listed Pharmaceutical Leader FOSUN PHARMA (02196) Poised to Unlock "Dual Value"

Stock News
·
Aug 15

FOSUN PHARMA (02196) Successfully Issues 1 Billion Yuan Medium-to-Long-Term Technology Innovation Bond, Leading Industry Development Through Innovation and Transformation

Stock News
·
Aug 14

Fosun Pharma's Unit Gets Acceptance for Tumor Drug Registration Application in China

MT Newswires Live
·
Aug 12

Fosun Pharmaceutical Sells 1 Billion Yuan Bonds; Shares Up 2%

MT Newswires Live
·
Aug 11